dreinrti.org
770-234-5035
Atlanta, GA

David B. Rein

Expertise

Public Health Economics
Health Outcomes
Infectious Disease Epidemiology
Adult Visual Disorders

Biography

David B. Rein, PhD, is a research economist in RTI's Public Health Economics program. His work focuses on outcomes research, cost-effectiveness simulations, applied econometrics, and program evaluation. He is an expert in childhood vaccination and the epidemiology of vision-threatening diseases, HIV/AIDS, and STDs. He currently leads several projects for the Centers for Disease Control and Prevention (CDC) and Health Resources and Services Administration and leads the economic component of several other larger-scale evaluations. From 1996 until 2000, Dr. Rein worked as an Oak Ridge Institute for Science and Education fellow in the CDC National Center for HIV, STD, and TB Prevention. He has extensive experience with quantitative and qualitative research methods, and he has lead-authored publications for The Lancet, Health Services Research, The American Journal of Public Health, Archives of Ophthalmology, Ophthalmology, Pediatrics, Obstetrics and Gynecology (The Green Journal), The American Journal of Managed Care, and Sexually Transmitted Diseases.

Education

PhD, Public Policy, Georgia Institute of Technology and Georgia State University (Joint PhD Program); MPA, Public Policy, Wagner School of Government, New York University; BA, Urban Studies, New York University.

Selected Publications

Rein, D.B., Wirth, K.E., Johnson, C.A., & Lee, P.P. (2007 Jul-Aug). Estimating quality-adjusted life year losses associated with visual field deficits using methodological approaches. Ophthalmic Epidemiology, 14 (4):258-264.

Rein, D.B., Saaddine, J.B., Wittenborn, J.S., Wirth, K.E., Hoerger, T.J., Venkat Narayan, K.M., Clemons, T., & Sorensen, S.W. (2007 Feb 21). Cost-effectiveness of vitamin therapy for age-related macular degeneration. Ophthalmology, 114 (7):1319-1326.

Rein, D.B., Hicks, K.A., Wirth, K.E., Billah, K., Finelli, L., Fiore, A.E., Hoerger, T.J., Bell, B.P., & Armstrong, G.L. (2007 Jan). Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States. Pediatrics, 119 (1):e12-e21.

Honeycutt, A.A., Harris, J.L., Khavjou, O., Buffington, J., Jones, S.T., & Rein, D.B. (Jan 2007). The costs and impacts of testing for hepatitis C virus antibody in public STD clinics. Public Health Reports, 122 (Suppl 2):55-62.

Armstrong, G.L., Billah, K., Rein, D.B., Hicks, K.A., Wirth, K.E., & Bell, B.P. (2007). The economics of routine childhood hepatitis A immunization in the United States: The impact of herd immunity. Pediatrics, 119 (1):E22-E29.

Rein, D.B., Zhang, P., Wirth, K.E., Lee, P.P., Hoerger, T.J., McCall, N., Klein, R., Tielsch, J.M., Vijan, S., & Saaddine, J. (December 2006). The economic burden of major adult visual disorders in the United States. Archives of Ophthalmology, 124 (12):1754-1760.

Rein, D.B., Honeycutt, A.A., Rojas-Smith, L., & Hersey, J.C. (2006 Sep). Impact of the CDC's Section 317 Immunization Grants Program funding on childhood vaccination coverage. American Journal of Public Health, 96 (9):1548-1553.

Rein, D.B., Fiore, A.E., & Bell, B.P. (2006 Feb 18). What's next for the hepatitis A vaccine? Lancet, 367 (9510):546-548.

Rein, D.B., Constantine, R.T., Orenstein, D., Chen, H., Jones, P., Brownstein, J.N., & Farris , R. (Jan 2006). A cost evaluation of the Georgia stroke and heart attack prevention program. Preventing Chronic Disease, 3 (1):A12.

Rein, D.B. (Aug 2005). A matter of classes: stratifying health care populations to produce better estimates of inpatient costs. Health Services Research, 40 (4):1217-1233.

View all publications by David B. Rein…